Visitacion, Jenny Rose R.
HRN: 09-29-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2022
CEFUROXIME 500MG (TAB)
11/07/2022
11/14/2022
ORAL
500 Mg
BID
PROM, S/p NSVD
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes